Contraindications to cisplatin based chemoradiotherapy in the treatment of cervical cancer in Sub-Saharan Africa
Authors:
- Orla McArdleOMOrla McArdle
- Joseph B. Kigula-MugambeJKJoseph B. Kigula-Mugambe
- 30 April 2007
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 83 (1) , 94-96
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcomeGynecologic Oncology, 2006
- Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: A retrospective analysis of 556 patients from IndiaRadiotherapy and Oncology, 2006
- HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancerGynecologic Oncology, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Adjuvant radiotherapy in carcinomas of the uterine cervix: the prognostic value of hemoglobin levelsInternational Journal of Gynecological Cancer, 2005
- Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer – a Meta-analysisClinical Oncology, 2002
- Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinomaCancer, 2001